Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 551 to 575 of 2555

TitleReference numberPublishedLast updated
Trabeculectomy with a biodegradable collagen matrix implant for glaucomaHTG656
Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)TA859
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and educationNG213
MRI-based technologies for assessing non-alcoholic fatty liver diseaseHTG655
Transcutaneous electrical stimulation of the trigeminal nerve for ADHDHTG653
Laparoscopic insertion of a magnetic ring for gastro-oesophageal reflux diseaseHTG654
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinomaTA857
Lenvatinib with pembrolizumab for untreated advanced renal cell carcinomaTA858
PredictSURE IBD for inflammatory bowel disease prognosis: ulcerative colitisMIB313
Diabetes in pregnancyQS109
Hip fracture: managementCG124
Hip fracture in adultsQS16
Percutaneous image-guided cryoablation of peripheral neuroma for chronic painHTG652
Upadacitinib for treating moderately to severely active ulcerative colitisTA856
Thyroid cancer: assessment and managementNG230
Tobacco: treating dependenceQS207
Avatrombopag for treating primary chronic immune thrombocytopeniaTA853
Cabozantinib for previously treated advanced hepatocellular carcinomaTA849
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyTA850
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancerTA851
Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatmentsTA852
Esketamine nasal spray for treatment-resistant depressionTA854
PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetesMIB312
Memokath 051 Ureter stent for ureteric obstructionHTG651
Cemiplimab for untreated PD-L1-positive advanced or metastatic non-small-cell lung cancer (terminated appraisal)TA848

Results per page

  1. 10
  2. 25
  3. 50
  4. All